Markers of systemic inflammation in children with hyperuricemia

Acta Paediatrica, International Journal of Paediatrics

Volumn 101, Issue 5, 2012, Pages 497-500

  Wasilewska, Anna ^a   Tenderenda, Edyta ^a   Taranta Janusz, Katarzyna ^a   Tobolczyk, Jolanta ^a   Stypułkowska, Justyna ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Hs CRP; Markers of systemic inflammation; MCP 1; Obesity; Uric acid

Indexed keywords

C REACTIVE PROTEIN; CREATININE; MONOCYTE CHEMOTACTIC PROTEIN 1; URIC ACID;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERURICEMIA; IN VITRO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBESITY; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; URIC ACID BLOOD LEVEL;

ADOLESCENT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHEMOKINE CCL2; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERURICEMIA; INFLAMMATION; MALE; OBESITY; URIC ACID;

EID: 84859605349     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2011.02582.x     Document Type: Article

References (19)

1. Selby JV, Friedman GD, Quesenberry CP Jr,. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990; 131: 1017-27.
2. Fang J, Alderman MH,. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404-10.
3. Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, et al., Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 2003; 107: 1991-7.
4. Masuo K, Kawaguchi H, Mikami H, Oqihara T, Tuck ML,. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42: 474-80.
5. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K,. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 2003; 18: 523-30.
6. Feig DI, Kang DH, Johnson RJ,. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-21.
7. Feig DI, Johnson RJ,. Hyperuricemia in childhood primary hypertension. Hypertension 2003; 42: 247-52.
8. Leyva F, Anker SD, Godsland IF, Teixeira M, Hellewell PG, Kox WJ, et al., Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J 1998; 19: 1814-22.
9. Kanellis J, Watanabe S, Li JH, Kanq DH, Li P, Nakaqawa T, et al., Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003; 41: 1287-93.
10. Hwu CM, Lin KH,. Uric acid and the development of hypertension. Med Sci Monit 2010; 16: RA224-30.
11. Soergel M, Kirschstein M, Busch C, Danne T, Gellermann J, Holl R, et al., Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 1997; 130: 178-84.
12. Saito M, Ishimitsu T, Minami J, Ono H, Ohrui M, Matsuoka H,. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 2003; 167: 73-9.
13. Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, et al., Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 2000; 23: 1835-9.
14. Litwin M, Michałkiewicz J, Niemirska A, Gackowska L, Kubiszewska I, Wierzbicka A, et al., Inflammatory activation in children with primary hypertension. Pediatr Nephrol 2009; 25: 1711-8.
15. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, et al., A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002; 13: 2888-97.
16. Krishnan E, Sokolove J,. Uric acid in heart disease: a new C-reactive protein? Curr Opin Rheumatol 2011; 23: 174-7.
17. Wellen KE, Hotamisligil GS,. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112: 1785-8.
18. Lyngdoh T, Marques-Vidal P, Paccaud F, Preisig M, Waeber G, Bochud M, et al., Elevated serum uric acid is associated with high circulating inflammatory cytokines in the population-based Colaus study. PLoS One 2011; 6:e19901. Epub 2011 May 20.
19. Baldwin W, McRae S, Marek G, Wymer D, Pannu V, Baylis C, et al., Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes 2011; 60: 1258-69.